Quick Heal Technologies Limited (NSE:QUICKHEAL)
India · Delayed Price · Currency is INR 140.00
-3.89 (-2.70%)
Aug 19, 2026, 3:29 PM IST
Quick Heal Technologies Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 2,488 | 2,610 | 2,795 | 2,918 | 2,781 | 3,419 | |
Revenue Growth | -6.64% | -6.62% | -4.19% | 4.91% | -18.66% | 2.66% |
Cost of Revenue | 41.2 | 42.8 | 96.8 | 97.8 | 122.2 | 150.8 |
Gross Profit | 2,447 | 2,567 | 2,699 | 2,820 | 2,659 | 3,268 |
Selling, General & Admin | 1,822 | 1,829 | 2,074 | 1,893 | 1,906 | 1,687 |
Other Operating Expenses | 996.6 | 1,032 | 636 | 696.9 | 691.2 | 502.8 |
Operating Expenses | 2,967 | 3,000 | 2,839 | 2,716 | 2,757 | 2,364 |
Operating Income | -520 | -432.7 | -140.6 | 104.1 | -98.2 | 904.2 |
Interest Expense | -1.4 | -2 | -2.2 | -1.3 | - | - |
Interest & Investment Income | - | - | 7.8 | 12.9 | 17.8 | 29 |
Currency Exchange Gain (Loss) | - | - | 1 | -1.5 | -7.1 | - |
Other Non Operating Income (Expenses) | 311.8 | 228.3 | 8.1 | 8 | 27.4 | 35.5 |
EBT Excluding Unusual Items | -209.6 | -206.4 | -125.9 | 122.2 | -60.1 | 968.7 |
Gain (Loss) on Sale of Investments | - | - | 134.6 | 122.5 | 100.8 | 102.5 |
Gain (Loss) on Sale of Assets | - | - | 1.3 | 2.7 | 39.5 | 16.5 |
Asset Writedown | - | - | - | -3.2 | - | -0.9 |
Pretax Income | -209.6 | -206.4 | 10 | 262.1 | 80.2 | 1,087 |
Income Tax Expense | -102.6 | -97.1 | -40.4 | 19.7 | 16.2 | 254.9 |
Net Income | -107 | -109.3 | 50.4 | 242.4 | 64 | 831.9 |
Net Income to Common | -107 | -109.3 | 50.4 | 242.4 | 64 | 831.9 |
Net Income Growth | - | - | -79.21% | 278.75% | -92.31% | -22.23% |
Shares Outstanding (Basic) | 55 | 55 | 54 | 53 | 56 | 59 |
Shares Outstanding (Diluted) | 55 | 55 | 55 | 54 | 56 | 60 |
Shares Change | 2.80% | 0.12% | 2.00% | -3.64% | -6.04% | -7.10% |
EPS (Basic) | -1.93 | -1.98 | 0.94 | 4.56 | 1.14 | 14.01 |
EPS (Diluted) | -1.93 | -1.98 | 0.91 | 4.48 | 1.14 | 13.94 |
EPS Growth | - | - | -79.69% | 292.98% | -91.82% | -16.28% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | - | -0.3 | -367.2 | 106.3 | 267.3 | 741.3 |
Free Cash Flow Per Share | - | -0.01 | -6.66 | 1.97 | 4.77 | 12.42 |
Dividend Per Share | - | - | - | 3.000 | 2.500 | 4.500 |
Dividend Growth | - | - | - | 20.00% | -44.44% | 12.50% |
Gross Margin | 98.34% | 98.36% | 96.54% | 96.65% | 95.61% | 95.59% |
Operating Margin | -20.90% | -16.58% | -5.03% | 3.57% | -3.53% | 26.45% |
Profit Margin | -4.30% | -4.19% | 1.80% | 8.31% | 2.30% | 24.33% |
Free Cash Flow Margin | - | -0.01% | -13.14% | 3.64% | 9.61% | 21.68% |
EBITDA | -375.4 | -293.7 | -24 | 213 | 25.7 | 1,045 |
EBITDA Margin | -15.09% | -11.25% | -0.86% | 7.30% | 0.92% | 30.57% |
D&A For EBITDA | 144.6 | 139 | 116.6 | 108.9 | 123.9 | 141 |
EBIT | -520 | -432.7 | -140.6 | 104.1 | -98.2 | 904.2 |
EBIT Margin | -20.90% | -16.58% | -5.03% | 3.57% | -3.53% | 26.45% |
Effective Tax Rate | - | - | - | 7.52% | 20.20% | 23.45% |
Revenue as Reported | 2,800 | 2,839 | 3,003 | 3,131 | 3,002 | 3,611 |
Advertising Expenses | - | - | 202 | 187.5 | 343 | 276.8 |